Android app Apple app link

REGENXBIO Inc. (RGNX) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$9.73
Day's range
$10.76

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/07/2026 Morgan Stanley Judah Frommer $18.00 $10.49   71.59%
07/01/2026 H.C. Wainwright Yi Chen $26.00 $11.98   117.03%
06/22/2026 Leerink Partners Mani Foroohar $18.00 $8.88   102.7%
06/22/2026 Robert W. Baird Brian Skorney $32.00 $8.91   259.1%
05/15/2026 Barclays Eliana Merle $12.00 $6.25   92.15%
03/05/2026 Morgan Stanley Judah Frommer $17.00 $8.72   94.95%
02/10/2026 Robert W. Baird Brian Skorney $27.00 $8.92   202.69%
01/29/2026 H.C. Wainwright Yi Chen $34.00 $11.52   195.14%
12/15/2025 Leerink Partners Mani Foroohar $20.00 $13.88   44.09%
01/07/2025 RBC Capital Luca Issi $30.00 $8.36   258.85%
11/15/2024 Morgan Stanley Judah Frommer $22.00 $11.14   97.49%
10/10/2024 Raymond James Danielle Brill $18.00 $9.19   95.97%
09/05/2024 H.C. Wainwright Yi Chen $39.00 $11.38   242.86%
06/24/2024 Stifel Nicolaus Annabel Samimy $40.00 $12.79   212.74%
06/07/2024 Goldman Sachs Paul Choi $38.00 $13.76   176.16%
05/15/2024 H.C. Wainwright Yi Chen $38.00 $15.80   140.51%
03/11/2024 H.C. Wainwright Yi Chen $36.00 $22.85   57.55%
03/08/2024 RBC Capital Luca Issi $35.00 $22.75   53.85%

Regenxbio Inc FAQ's

Regenxbio Inc has been rated by research analysts at Morgan Stanley, H.C. Wainwright, Leerink Partners, Robert W. Baird, Barclays, UBS in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.